Buprenorphine – A First Line Consideration for Pain Management in Serious Illness

Wednesday, September 17, 2025, 1:30 PM - 4:45 PM, Virtual and in person at Jack Byrne Center, Dartmouth Hitchcock Medical Center, Lebanon, NH

AMA PRA Category 1 Credits™ (3.00 hours), ACPE Contact Hours (3.00 hours), ANCC Nursing Contact Hours (3.00 hours), CME-Designated Participation Credit (3.00 hours)

In this 3-hour hybrid interactive course, clinicians caring for people with serious illness will learn about the different formulations of buprenorphine used for pain management as well as for opioid use disorder. Clinicians will apply their knowledge about the pharmacology of buprenorphine to discuss applications for use in the hospital, ambulatory and end-of-life care settings through the use of interactive case-based discussions.

1. Discuss the unique pharmacologic properties of buprenorphine, including the use of various formulations, indications and contraindications to treat pain.
2. Identify patients that may benefit from the use of buprenorphine.
3. Implement strategies to increase confidence in prescribing and managing buprenorphine therapeutic regimens across care settings.

There is no fee to register for this program, but advance registration is required for planning purposes.

The registration deadline is 1 week prior to the activity date. For registration questions, please call (603) 653-1234 or email [email protected].

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Medical Association (AMA)
Dartmouth Health designates this Live Activity for a maximum of 3.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Live Activity for a maximum of 3.00 ANCC contact hours. 

Accreditation Council of Pharmacy Education (ACPE)
Dartmouth Health designates this knowledge-based activity for a maximum of 3.00 hour. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

UAN JA0000201-0000-25-019-L01-P | UAN JA0000201-0000-25-019-L01-T

All other learners may claim CME-designated participation credit. Consult your professional licensing board regarding the applicability and acceptance of CME-designated participation credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Receiving Credit
The following steps must be completed in order to receive credit for this event:

• Register for the event online

• Attend the event or session(s) 

• Complete the online evaluation (located under My Account in the top menu) - Must be submitted within 30 days after the activity

For questions or technical support, please email [email protected] or call (603) 653-1234.

 

Pharmacists/Pharmacy Technicians
If you wish to apply for ACPE credit, you will need to enter your NABP ePID# and Date of Birth in your CE Profile by following these steps:

• Log in to Dartmouth Health's CE portal.

• From the My Account Menu select Profile.

• Enter your Date of Birth (Month and Day)

• In the Credentials section, select NABP ePID# from the drop down and enter your ID number.

• Scroll down to the bottom of the screen and click Submit

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Wednesday, September 17, 2025